Business As Usual...Until It Isn't: MDPNP's Impact on 340B with Julie Crozier, CEO of Secure340B

Episode notes

Send us Fan Mail Schedule an Rx Assessment With Medicare’s Maximum Fair Price (MFP) rebates officially underway and the 340B rebate mechanism on hold, pharmacy owners are left navigating one of the grayest areas the industry has seen in years. In this episode, Scotty Sykes, CPA, CFP®, Bonnie Bond, CPA, MBA, and Austin Murray sit down with Julie Crozier, CEO at @secure340b to unpack how MDPNP is colliding with 340B and what pharmacies should be paying attention to right now. We cover: How MDPNP and MFP rebates are flowing today The duplicate discount problem no one is reconciling Beacon’s role and why future reconciliation risk matters Dispensing fee pressure, CE relationships, and contract implications Practical considerations if TPAs or covered entities push for carve-outs And more! More About Our Guest: As CEO of Secure340B, Julie is responsible for formulating and executing strategic plans and technology to deliver critical and timely intel to 340B stakeholders. Julie has over 25 years of pharmacy experience including co-founding, growing and leading a pharmacy software company, Macro Helix, which was acquired by McKesson Corp (NYSE: MCK) in 2012.